Web Desc
Viral Immunity
joint with HIV Vaccines
Organizer(s): Jonathan W. Yewdell, Akiko Iwasaki, Nicole L. La Gruta and Jack R. Bennink
Date: March 21 - 26, 2010
Location: Fairmont Banff Springs, Banff, AB, Canada
Supported by The Directors' Fund
Summary of Meeting:
The most exciting recent advances in viral immunity include the increased understanding of the role of innate immune mechanisms, interaction between innate and adaptive immunity, pathogen manipulation of host responses, and activation of immune responses and generation of immune memory. Despite these advances, basic mechanisms of anti-viral immunity are poorly characterized particularly for chronic infections. Efforts are also required to exploit recent research advances to improve vaccine design and therapeutic intervention. This meeting will include both innate and adaptive immunity and juxtapose animal models with human studies as it attempts to foster collaborative efforts between attending viral immunologists and the HIV vaccine researchers in the joint meeting. Expert talks in plenary sessions will encompass the latest in critical areas of viral immunity. Workshops and additional presentations will cover provocative and cutting-edge results from attendees. The meeting objective is to accelerate progress in understanding and manipulating anti-viral immunity to improve human health.
Scholarship Deadline: November 19 2009
Discounted Abstract Deadline: November 19 2009
Abstract Deadline: December 23 2009
Discounted Registration Deadline: January 21 2010
We gratefully acknowledge additional support for this conference from:
Burroughs Wellcome Fund
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13AI085598-01
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

Program

Sunday, March 21 | 3:00PM - 7:30PM
Registration
Room: Van Horne Foyer


Sunday, March 21 | 6:15PM - 7:15PM
Refreshments
Room: Van Horne Foyer


Sunday, March 21 | 7:15PM - 7:30PM
Orientation for New Attendees and New Investigators (Joint)
Room: Van Horne Ballroom A-B
Keystone Symposia's Chief Scientific Officer, Dr. Andy Robertson, to lead discussion in a 'What to Expect during your Attendance' for interested delegates.

Sunday, March 21 | 7:30PM - 9:30PM
Keynote Session (Joint)
Room: Van Horne Ballroom A-B

Speaker 1 of 2
Bruce D. Walker, Ragon Institute of MGH, MIT and Harvard, USA
Durable Control of HIV Infection: Implications for Vaccine Design

Sunday, March 21 | 7:30PM - 9:30PM
Keynote Session (Joint)
Room: Van Horne Ballroom A-B

Speaker 2 of 2
Peter C. Doherty, University of Melbourne, Australia
Anti-Viral Immunity: Lessons from Influenza Virus

Monday, March 22 | 6:30AM - 8:00AM
Breakfast
Room: Mezzanine 2


Monday, March 22 | 8:00AM - 11:15AM
Innate Recognition of Virus Infection
Room: Van Horne C/Shaughnessy

Speaker 1 of 7
* Herbert (Skip) W. Virgin, Vir Biotechnology, USA

Monday, March 22 | 8:00AM - 11:15AM
Innate Recognition of Virus Infection
Room: Van Horne C/Shaughnessy

Speaker 2 of 7
Ruslan Medzhitov, HHMI/Yale University School of Medicine, USA
Innate Recognition of Endogenous Retroviruses

Monday, March 22 | 8:00AM - 11:15AM
Innate Recognition of Virus Infection
Room: Van Horne C/Shaughnessy

Speaker 3 of 7
Nelson Cesar Di Paolo, Emory University, USA
Short Talk: Adenovirus Binding to beta3 Integrins Activates Innate Antiviral Immunity Independently of the Virus DNA Recognition by Intracellular Sensors

Monday, March 22 | 8:00AM - 11:15AM
Innate Recognition of Virus Infection
Room: Van Horne C/Shaughnessy

Speaker 4 of 7
Michael Gale, Jr., University of Washington, USA
Regulation of Pathogen Recognition Receptor Signaling and Innate Immunity by Hepatitis C Virus

Monday, March 22 | 8:00AM - 11:15AM
Innate Recognition of Virus Infection
Room: Van Horne C/Shaughnessy

Speaker 5 of 7
Thirumala-Devi Kanneganti, St. Jude Children's Research Hospital, USA
NLRs in Innate Immunity to Influenza Virus

Monday, March 22 | 8:00AM - 11:15AM
Innate Recognition of Virus Infection
Room: Van Horne C/Shaughnessy

Speaker 6 of 7
Sammy Bedoui, University of Melbourne, Australia
Short Talk: Priming of CD8 T Cell Immunity to Herpes Simplex Virus Type 1 Requires Cognate TLR3 Expression in vivo

Monday, March 22 | 8:00AM - 11:15AM
Innate Recognition of Virus Infection
Room: Van Horne C/Shaughnessy

Speaker 7 of 7
Akiko Iwasaki, HHMI/Yale University School of Medicine, USA
Toll-Like Receptors in Viral Immunity

Monday, March 22 | 8:00AM - 11:15AM
Adaptive Immunity/T- and B-Cell Responses
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 1 of 7
* Marcus Altfeld, Heinrich-Pette-Institute, Germany


Monday, March 22 | 8:00AM - 11:15AM
Adaptive Immunity/T- and B-Cell Responses
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 2 of 7
Kim J. Hasenkrug, NIAID, National Institutes of Health, USA
T Cell and B Cell Memory in Protection against Mouse Retrovirus Infection


Monday, March 22 | 8:00AM - 11:15AM
Adaptive Immunity/T- and B-Cell Responses
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 3 of 7
Richard A. Koup, NIAID, National Institutes of Health, USA
Adaptive Immunity to HIV


Monday, March 22 | 8:00AM - 11:15AM
Adaptive Immunity/T- and B-Cell Responses
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 4 of 7
Hendrik Streeck, Military HIV Research Program, USA
Short Talk: Increased Control of Viral Replication by HIV-1-Specific CD8+ T Cells Mediated by HIV-Specific CD4+ T Helper Signals


Monday, March 22 | 8:00AM - 11:15AM
Adaptive Immunity/T- and B-Cell Responses
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 5 of 7
Barbara L. Shacklett, University of California, Davis, USA
Mucosal Immune Responses to HIV Infection


Monday, March 22 | 8:00AM - 11:15AM
Adaptive Immunity/T- and B-Cell Responses
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 6 of 7
Barton F. Haynes, Duke University Medical Center, USA
B-Cell Immune Responses to Acute HIV Infection


Monday, March 22 | 8:00AM - 11:15AM
Adaptive Immunity/T- and B-Cell Responses
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 7 of 7
Ann J. Hessell, Oregon Health & Science University, USA
Short Talk: A Non-Fucosylated Variant of the Anti-HIV-1 MAb b12
Results in Greatly Increased ADCC and ADCVI and Binds FcgammaRIIIa with Higher Affinity than Wild-Type b12


Monday, March 22 | 9:20AM - 9:40AM
Coffee Break
Room: Van Horne Foyer


Monday, March 22 | 11:15AM - 11:15AM
On Own for Lunch and Recreation


Monday, March 22 | 11:15AM - 1:00PM
Poster Setup
Room: Mezzanine 2


Monday, March 22 | 1:00PM - 10:00PM
Poster Viewing
Room: Mezzanine 2


Monday, March 22 | 1:00PM - 2:30PM
Hands-on Computer Session on Los Alamos Sequence Database
This session is from HIV Vaccines
Room: Ivor Petrak
Maximum attendance: 60. Interested participants may sign up at the meeting on a first-come, first-serve basis.
Speaker 1 of 2
* Bette Tina Marie Korber, Los Alamos National Laboratory, USA


Monday, March 22 | 1:00PM - 2:30PM
Hands-on Computer Session on Los Alamos Sequence Database
This session is from HIV Vaccines
Room: Ivor Petrak
Maximum attendance: 60. Interested participants may sign up at the meeting on a first-come, first-serve basis.
Speaker 2 of 2
* Brian T. Foley, Los Alamos National Lab, USA


Monday, March 22 | 2:30PM - 4:30PM
Workshop 1: Advances in Vaccine Development: Clinical Trials
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 1 of 7
* M. Juliana McElrath, Fred Hutchinson Cancer Research Center, USA


Monday, March 22 | 2:30PM - 4:30PM
Workshop 1: Advances in Vaccine Development: Clinical Trials
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 2 of 7
* Nelson L. Michael, Walter Reed Army Institute of Research, USA
RV 144 Update: Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thai Adults


Monday, March 22 | 2:30PM - 4:30PM
Workshop 1: Advances in Vaccine Development: Clinical Trials
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 3 of 7
Jill Gilmour, International AIDS Vaccine Initiative, UK
Short Talk: Induction of Viral Inhibition in Clinical HIV Vaccine Trials of Diverse Immunogens


Monday, March 22 | 2:30PM - 4:30PM
Workshop 1: Advances in Vaccine Development: Clinical Trials
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 4 of 7
Julia Rood, University of Pennsylvania, USA
Short Talk: HIV-Specific CD8+ T-Cells of Vaccinees Exhibit Per-Cell Cytotoxic Capacity Comparable to Those of Progressors


Monday, March 22 | 2:30PM - 4:30PM
Workshop 1: Advances in Vaccine Development: Clinical Trials
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 5 of 7
Erica Andersen-Nissen, Hutchinson Centre Research Institute of South Africa, South Africa
Short Talk: Systemic Innate Immune Responses to a DNA/MVA Candidate HIV Vaccine


Monday, March 22 | 2:30PM - 4:30PM
Workshop 1: Advances in Vaccine Development: Clinical Trials
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 6 of 7
William C. Adams, Columbia University, USA
Short Talk: Adenovirus Type-35 Vectors Block Human CD4+ T Cell Activation by CD46 Ligation


Monday, March 22 | 2:30PM - 4:30PM
Workshop 1: Advances in Vaccine Development: Clinical Trials
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 7 of 7
Ruth M. Ruprecht, Texas Biomedical Research Institute, USA
Short Talk: Prevention of Systemic Infection by a Multigenic Recombinant Protein Vaccine after Heterologous R5 Clade C SHIV Challenge: Correlates of Protection


Monday, March 22 | 4:30PM - 5:00PM
Coffee Available
Room: Van Horne Foyer


Monday, March 22 | 5:00PM - 7:00PM
Innate Immunity to Viruses
Room: Van Horne C/Shaughnessy

Speaker 1 of 5
* Akiko Iwasaki, HHMI/Yale University School of Medicine, USA

Monday, March 22 | 5:00PM - 7:00PM
Innate Immunity to Viruses
Room: Van Horne C/Shaughnessy

Speaker 2 of 5
Herbert (Skip) W. Virgin, Vir Biotechnology, USA
'Virus-Host Susceptibility Gene' Interactions Control Chronic Inflammatory Disease

Monday, March 22 | 5:00PM - 7:00PM
Innate Immunity to Viruses
Room: Van Horne C/Shaughnessy

Speaker 3 of 5
Doris Wilflingseder, Insbruck Medical University, Austria
Short Talk: Complement as an Endogenous Adjuvant for Dendritic Cell-Mediated Induction of Retrovirus-Specific CTLs

Monday, March 22 | 5:00PM - 7:00PM
Innate Immunity to Viruses
Room: Van Horne C/Shaughnessy

Speaker 4 of 5
Ofer Mandelboim, Hebrew University, Israel
Cellular and Viral microRNAs Controlling Immune Response to Stress

Monday, March 22 | 5:00PM - 7:00PM
Innate Immunity to Viruses
Room: Van Horne C/Shaughnessy

Speaker 5 of 5
Wayne M. Yokoyama, Washington University School of Medicine, USA
NK Cells, CTLs, and Virus Infection: Missing-Self in Action?

Monday, March 22 | 5:00PM - 7:00PM
Control of HIV Infection
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 1 of 4
* Andrew J. McMichael, Oxford University, UK
Vaccine Design: Lessons from Acute HIV-1 Infection


Monday, March 22 | 5:00PM - 7:00PM
Control of HIV Infection
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 2 of 4
Mark Brockman, Simon Fraser University, Canada
Short Talk: Reduced Replication Capacity of Recombinant Viruses Encoding Acute/Early HIV-1 Gag-Protease Sequences from Individuals Expressing Protective HLA Class I Alleles


Monday, March 22 | 5:00PM - 7:00PM
Control of HIV Infection
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 3 of 4
R. Paul Johnson, Harvard Medical School, USA
Lessons Learned from Live Attenuated SIV


Monday, March 22 | 5:00PM - 7:00PM
Control of HIV Infection
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 4 of 4
Guido Silvestri, Emory University School of Medicine, USA
Nonpathogenic Natural SIV Infections


Monday, March 22 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Mezzanine 2


Monday, March 22 | 7:30PM - 10:00PM
Poster Session 1
Room: Mezzanine 2


Tuesday, March 23 | 6:30AM - 8:00AM
Breakfast
Room: Mezzanine 2


Tuesday, March 23 | 8:00AM - 11:15AM
T-Cell Immunity to Viruses
Room: Van Horne C/Shaughnessy

Speaker 1 of 7
* Jack R. Bennink, NIAID, National Institutes of Health, USA

Tuesday, March 23 | 8:00AM - 11:15AM
T-Cell Immunity to Viruses
Room: Van Horne C/Shaughnessy

Speaker 2 of 7
Nicole L. La Gruta, University of Melbourne, Australia
Dissection of CTL Immunodominance Determinants Following Viral Infection

Tuesday, March 23 | 8:00AM - 11:15AM
T-Cell Immunity to Viruses
Room: Van Horne C/Shaughnessy

Speaker 3 of 7
Guna Karupiah, John Curtin School of Medical Research, Australian National University, Australia
Short Talk: The Biological Significance of Proliferation-Independent Expansion of Antigen-Specific CD8+ T Cells through Receptor Sharing

Tuesday, March 23 | 8:00AM - 11:15AM
T-Cell Immunity to Viruses
Room: Van Horne C/Shaughnessy

Speaker 4 of 7
Andrea Lynn Cox, Johns Hopkins University, USA
Analysis of T Cells Chasing Hepatitis C Virus Escape Variants

Tuesday, March 23 | 8:00AM - 11:15AM
T-Cell Immunity to Viruses
Room: Van Horne C/Shaughnessy

Speaker 5 of 7
Ann B. Hill, Oregon Health & Science University, USA
CD8+ T Cells and Cytomegalovirus: A Dangerous Obsession?

Tuesday, March 23 | 8:00AM - 11:15AM
T-Cell Immunity to Viruses
Room: Van Horne C/Shaughnessy

Speaker 6 of 7
Linda S. Cauley, University of Connecticut Health Center, USA
Short Talk: Cause and Effects of Prolonged Lymph Node Hypertrophy after Influenza Infection

Tuesday, March 23 | 8:00AM - 11:15AM
T-Cell Immunity to Viruses
Room: Van Horne C/Shaughnessy

Speaker 7 of 7
J. Lindsay Whitton, The Scripps Research Institute, USA
CD8+ T Cell Responses To Infection: A Tale Of Two Viruses

Tuesday, March 23 | 8:00AM - 11:45AM
Neutralizing Antibody
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 1 of 7
Eric Hunter, Emory University, USA
and


Tuesday, March 23 | 8:00AM - 11:45AM
Neutralizing Antibody
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 2 of 7
Cynthia A. Derdeyn, Emory University, USA
Recently Transmitted HIV and the Early Neutralizing Antibody Response


Tuesday, March 23 | 8:00AM - 11:45AM
Neutralizing Antibody
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 3 of 7
Peter D. Kwong, NIAID, National Institutes of Health, USA
Antibody VRC01: To Be or Not To Be Like CD4


Tuesday, March 23 | 8:00AM - 11:45AM
Neutralizing Antibody
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 4 of 7
Sriram Subramaniam, University of British Columbia, Canada
Molecular Architecture of Trimeric SIV and HIV-1 Envelope Glycoproteins


Tuesday, March 23 | 8:00AM - 11:45AM
Neutralizing Antibody
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 5 of 7
Quentin J. Sattentau, Sir William Dunn School of Pathology, UK
Antigen and Adjuvant Design for Antibody-Based HIV-1 Vaccination


Tuesday, March 23 | 8:00AM - 11:45AM
Neutralizing Antibody
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 6 of 7
* Lynn Morris, National Institute for Communicable Diseases, South Africa
How Does Neutralization Breadth Develop in HIV Infection


Tuesday, March 23 | 8:00AM - 11:45AM
Neutralizing Antibody
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 7 of 7
Joseph Joyce, Merck & Co., Inc., USA
Short Talk: Vaccination with Peptide Mimetics of the gp41 Pre-Hairpin Fusion Intermediate Yields Neutralizing Antisera Against HIV-1 Isolates


Tuesday, March 23 | 9:20AM - 9:40AM
Coffee Break
Room: Van Horne Foyer


Tuesday, March 23 | 11:15AM - 11:15AM
On Own for Lunch and Recreation


Tuesday, March 23 | 11:15AM - 1:00PM
Poster Setup
Room: Mezzanine 2


Tuesday, March 23 | 1:00PM - 10:00PM
Poster Viewing
Room: Mezzanine 2


Tuesday, March 23 | 1:00PM - 2:30PM
Hands-on Computer Session on Los Alamos Sequence Database
This session is from HIV Vaccines
Room: Ivor Petrak
Maximum attendance: 60. Interested participants may sign up at the meeting on a first-come, first-serve basis.
Speaker 1 of 2
* Bette Tina Marie Korber, Los Alamos National Laboratory, USA


Tuesday, March 23 | 1:00PM - 2:30PM
Hands-on Computer Session on Los Alamos Sequence Database
This session is from HIV Vaccines
Room: Ivor Petrak
Maximum attendance: 60. Interested participants may sign up at the meeting on a first-come, first-serve basis.
Speaker 2 of 2
* Brian T. Foley, Los Alamos National Lab, USA


Tuesday, March 23 | 2:30PM - 4:30PM
Workshop 1: ANTI-VIRAL CD8 T CELL RESPONSES
Room: Van Horne Ballroom C

Speaker 1 of 2
* Tania H. Watts, University of Toronto, Canada

Tuesday, March 23 | 2:30PM - 4:30PM
Workshop 1: ANTI-VIRAL CD8 T CELL RESPONSES
Room: Van Horne Ballroom C

Speaker 2 of 2
* David C. Tscharke, Australian National University, Australia

Tuesday, March 23 | 2:30PM - 3:30PM
Workshop 1A: CD8 T Cell Memory
Room: Van Horne Ballroom C

Speaker 1 of 4
Jeffrey C. Nolz, University of Iowa, USA
Multiple Antigen Encounters Decrease the Protective Capacity of the Ensuing Memory CD8 T Cell Population Against Chronic LCMV Infection

Tuesday, March 23 | 2:30PM - 3:30PM
Workshop 1A: CD8 T Cell Memory
Room: Van Horne Ballroom C

Speaker 2 of 4
John Rutigliano, St. Jude Children's Research Hospital, USA
Development and Differentiation of Memory CD8+ T Cells in Influenza Infection

Tuesday, March 23 | 2:30PM - 3:30PM
Workshop 1A: CD8 T Cell Memory
Room: Van Horne Ballroom C

Speaker 3 of 4
Hélène Decaluwe, CHU Sainte-Justine, Canada
Gamma c Deficiency Precludes CD8+ T Cell Memory Despite Formation of Potent Anti-Viral T Cell Effectors

Tuesday, March 23 | 2:30PM - 3:30PM
Workshop 1A: CD8 T Cell Memory
Room: Van Horne Ballroom C

Speaker 4 of 4
Amol Suryawanshi, Georgia Regents University, USA
Galectin-9/TIM-3 Interaction Regulates Virus-Specific Primary and Memory CD8+T Cell Response

Tuesday, March 23 | 2:30PM - 4:30PM
Workshop 2: Novel Vector and Adjuvant Development
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 1 of 9
* Gerald H. Voss, GlaxoSmithKline Biologicals, Belgium


Tuesday, March 23 | 2:30PM - 4:30PM
Workshop 2: Novel Vector and Adjuvant Development
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 2 of 9
John K. Rose, Yale University School of Medicine, USA
Short Talk: Strong Protection Against SIVsmE660 Mucosal Challenge Conferred by a Novel, Heterologous, Prime-Boost Vaccine Regimen


Tuesday, March 23 | 2:30PM - 4:30PM
Workshop 2: Novel Vector and Adjuvant Development
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 3 of 9
Mauricio A. Martins, University of Miami, USA
Short Talk: Recombinant Yellow Fever Vaccine Virus 17D Expressing SIVmac239 Gag Induces SIV-Specific CD8+ T Cell Responses in Rhesus Macaques


Tuesday, March 23 | 2:30PM - 4:30PM
Workshop 2: Novel Vector and Adjuvant Development
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 4 of 9
* Nancy L. Haigwood, Oregon Health & Science University, USA
Short Talk: Novel VLPs Rapidly Induce High Titer Neutralizing Antibodies when Combined with DNA Vaccines in Rabbits


Tuesday, March 23 | 2:30PM - 4:30PM
Workshop 2: Novel Vector and Adjuvant Development
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 5 of 9
Adrian B. McDermott, National Institutes of Health, USA
Short Talk: Control of Pathogenic SIVmac239 Following Electroporated DNA + IL-12 Prime and Adenovirus 5 Boost in a Study Designed to Compare Priming Strategies in the NHP Model


Tuesday, March 23 | 2:30PM - 4:30PM
Workshop 2: Novel Vector and Adjuvant Development
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 6 of 9
Magdalini Moutaftsi, Infectious Disease Research Institute, USA
Short Talk: Glucopyranosyl Lipid A (GLA), a Synthetic TLR4 Vaccine Adjuvant, Induces Potent Th1-Promoting Immune Responses


Tuesday, March 23 | 2:30PM - 4:30PM
Workshop 2: Novel Vector and Adjuvant Development
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 7 of 9
Anna Bershteyn, Massachusetts Institute of Technology, USA
Short Talk: Versatile Lipid-Based Vaccine Carriers Elicit CTL and Antibody Responses to Surface-Conjugated or Encapsulated Antigen


Tuesday, March 23 | 2:30PM - 4:30PM
Workshop 2: Novel Vector and Adjuvant Development
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 8 of 9
Ben Berkhout, University of Amsterdam, Academic Medical Center, Netherlands
Short Talk: Live Attenuated SIV: Characterising the Role of Vaccine Persistence in Protection


Tuesday, March 23 | 2:30PM - 4:30PM
Workshop 2: Novel Vector and Adjuvant Development
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 9 of 9
Tomas Hanke, University of Oxford, UK
Short Talk: Long Peptides Induce Polyfunctional Macaque T Cells Against Conserved Regions of HIV-1 with Superior Breadth to Single-Gene Vaccines


Tuesday, March 23 | 3:30PM - 4:30PM
Workshop 1B: Virus Specific CD8 T Cells
Room: Van Horne Ballroom C

Speaker 1 of 4
Alice E. Denton, University of Melbourne, Australia
Epigenetic Regulation in CD8+ T Cell Differentiation

Tuesday, March 23 | 3:30PM - 4:30PM
Workshop 1B: Virus Specific CD8 T Cells
Room: Van Horne Ballroom C

Speaker 2 of 4
Bailey E. Freeman, Oregon Health & Science University, USA
Cytokine-Mediated Regulation of CD8+ T Cell Responses during LCMV Infection

Tuesday, March 23 | 3:30PM - 4:30PM
Workshop 1B: Virus Specific CD8 T Cells
Room: Van Horne Ballroom C

Speaker 3 of 4
Lila Ann Farrington, University of California, San Francisco, USA
Virus-Infected Cells are Extremely Resistant to CTL-Mediated Killing

Tuesday, March 23 | 3:30PM - 4:30PM
Workshop 1B: Virus Specific CD8 T Cells
Room: Van Horne Ballroom C

Speaker 4 of 4
Silvia Ariotti, Netherlands Cancer Institute, Netherlands
In vivo Imaging of Target Localization by Virus-Specific Cytotoxic T Lymphocytes

Tuesday, March 23 | 4:30PM - 5:00PM
Coffee Available
Room: Van Horne Foyer


Tuesday, March 23 | 5:00PM - 7:00PM
Routes of Antigen Presentation
Room: Van Horne C/Shaughnessy

Speaker 1 of 5
* Nicole L. La Gruta, University of Melbourne, Australia

Tuesday, March 23 | 5:00PM - 7:00PM
Routes of Antigen Presentation
Room: Van Horne C/Shaughnessy

Speaker 2 of 5
Laurence C. Eisenlohr, Children's Hospital of Philadelphia and University of Pennsylvania, USA
A Proteasome- and TAP-Dependent MHC Class II-Restricted Presentation Pathway that Stimulates a Substantial Portion of the Antiviral CD4+ T Cell Response: Part 2

Tuesday, March 23 | 5:00PM - 7:00PM
Routes of Antigen Presentation
Room: Van Horne C/Shaughnessy

Speaker 3 of 5
Margarita Del Val, Centro de Biología Molecular Severo Ochoa, Spain
Short Talk: Furin-Processed Antigens Targeted to the Secretory Route Elicit Functional TAP1-/- CD8+ T Lymphocytes in vivo

Tuesday, March 23 | 5:00PM - 7:00PM
Routes of Antigen Presentation
Room: Van Horne C/Shaughnessy

Speaker 4 of 5
Sylvie Le Gall, Massachusetts General Hospital, Harvard Medical School, USA
Deciphering HIV Epitope Production: Implications for Immunogen Design

Tuesday, March 23 | 5:00PM - 7:00PM
Routes of Antigen Presentation
Room: Van Horne C/Shaughnessy

Speaker 5 of 5
William R. Heath, University of Melbourne, Australia
Viral Antigen Presentation to Naïve and Memory CD8+ T Cells

Tuesday, March 23 | 5:00PM - 7:00PM
Innate Immunity
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 1 of 6
* Bali Pulendran, Stanford University School of Medicine, USA


Tuesday, March 23 | 5:00PM - 7:00PM
Innate Immunity
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 2 of 6
Marcus Altfeld, Heinrich-Pette-Institute, Germany
Natural Killer Cells in HIV-1 Infection


Tuesday, March 23 | 5:00PM - 7:00PM
Innate Immunity
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 3 of 6
Silke Paust, Baylor College of Medicine, USA
Short Talk: Critical Role for CXCR6 in NK Cell Mediated Adaptive Immunity to Viruses


Tuesday, March 23 | 5:00PM - 7:00PM
Innate Immunity
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 4 of 6
Mariapia A. Degli-Esposti, LEI, University of Western Australia, Australia
NK/DC Crosstalk and Regulation of Adaptive Immunity


Tuesday, March 23 | 5:00PM - 7:00PM
Innate Immunity
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 5 of 6
Veronica Anna Sofia Tjomsland, University of Linköping, Sweden
Short Talk: Receptors and Pathways Utilized by Dendritic Cells for Antigen Presentation of Free and Complement Opsonized HIV


Tuesday, March 23 | 5:00PM - 7:00PM
Innate Immunity
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 6 of 6
Jay A. Berzofsky, NCI, National Institutes of Health, USA
Short Talk: Innate and Adaptive Immune Correlates of Vaccine-Induced Control of Mucosal Transmission of SIV in Macaques


Tuesday, March 23 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Mezzanine 2


Tuesday, March 23 | 7:30PM - 10:00PM
Poster Session 2
Room: Mezzanine 2


Wednesday, March 24 | 6:30AM - 8:00AM
Breakfast
Room: Mezzanine 2


Wednesday, March 24 | 8:00AM - 11:15AM
Vaccines: Immunologic Mechanisms of Action (Joint)
Room: Van Horne Ballroom A-B

Speaker 1 of 7
* Kim J. Hasenkrug, NIAID, National Institutes of Health, USA

Wednesday, March 24 | 8:00AM - 11:15AM
Vaccines: Immunologic Mechanisms of Action (Joint)
Room: Van Horne Ballroom A-B

Speaker 2 of 7
Bali Pulendran, Stanford University School of Medicine, USA
Lessons from Yellow Fever Vaccine

Wednesday, March 24 | 8:00AM - 11:15AM
Vaccines: Immunologic Mechanisms of Action (Joint)
Room: Van Horne Ballroom A-B

Speaker 3 of 7
Ian Frazer, TRI, Australia
Lessons from the Human Papillomavirus Vaccines

Wednesday, March 24 | 8:00AM - 11:15AM
Vaccines: Immunologic Mechanisms of Action (Joint)
Room: Van Horne Ballroom A-B

Speaker 4 of 7
Shane Crotty, La Jolla Institute for Immunology, USA
Lessons from the Smallpox Vaccine: Follicular Helper CD4+ T Cell (Tfh) Differentiation and Neutralizing Antibodies

Wednesday, March 24 | 8:00AM - 11:15AM
Vaccines: Immunologic Mechanisms of Action (Joint)
Room: Van Horne Ballroom A-B

Speaker 5 of 7
Mark Stephen de Souza, AFRIMS, Thailand
Short Talk: Immunogenicity of the Thai Phase III (RV144) HIV Vaccine Regimen

Wednesday, March 24 | 8:00AM - 11:15AM
Vaccines: Immunologic Mechanisms of Action (Joint)
Room: Van Horne Ballroom A-B

Speaker 6 of 7
Monica Vaccari, NCI, National Institutes of Health, USA
Short Talk: HIV/SIV Vaccine Efficacy Dependent on the Dose of SIVmac251 Challenge Exposure in Macaques

Wednesday, March 24 | 8:00AM - 11:15AM
Vaccines: Immunologic Mechanisms of Action (Joint)
Room: Van Horne Ballroom A-B

Speaker 7 of 7
M. Juliana McElrath, Fred Hutchinson Cancer Research Center, USA
Lessons from the STEP Trial and the Current Clinical Pipeline

Wednesday, March 24 | 9:50AM - 10:10AM
Coffee Break
Room: Van Horne Foyer


Wednesday, March 24 | 11:15AM - 11:15AM
On Own for Lunch and Recreation


Wednesday, March 24 | 11:15AM - 1:00PM
Poster Setup
Room: Mezzanine 2


Wednesday, March 24 | 1:00PM - 10:00PM
Poster Viewing
Room: Mezzanine 2


Wednesday, March 24 | 4:30PM - 5:00PM
Coffee Available
Room: Van Horne Foyer


Wednesday, March 24 | 5:00PM - 7:00PM
Imaging of the Antiviral Immune Response (Joint)
Room: Van Horne Ballroom A-B

Speaker 1 of 5
* Jonathan W. Yewdell, NIAID, National Institutes of Health, USA

Wednesday, March 24 | 5:00PM - 7:00PM
Imaging of the Antiviral Immune Response (Joint)
Room: Van Horne Ballroom A-B

Speaker 2 of 5
Heather D. Hickman, NIAID, National Institutes of Health, USA
Intravital Imaging of the CD8+ T Cell Response to Virus

Wednesday, March 24 | 5:00PM - 7:00PM
Imaging of the Antiviral Immune Response (Joint)
Room: Van Horne Ballroom A-B

Speaker 3 of 5
Matteo Iannacone, Fondazione Centro San Raffaele, Italy
Short Talk: Lymph Node Subcapsular Sinus Macrophages Confer Resistance to CNS
Invasion Upon Peripheral Infection With a Neurotropic Virus


Wednesday, March 24 | 5:00PM - 7:00PM
Imaging of the Antiviral Immune Response (Joint)
Room: Van Horne Ballroom A-B

Speaker 4 of 5
Ashley T. Haase, University of Minnesota, USA
In Vivo Imaging of the Cellular Immune Response to Viral Infections

Wednesday, March 24 | 5:00PM - 7:00PM
Imaging of the Antiviral Immune Response (Joint)
Room: Van Horne Ballroom A-B

Speaker 5 of 5
Ronald N. Germain, NIAID, National Institutes of Health, USA
Intravital Imaging of Adaptive Immune Effector Activity

Wednesday, March 24 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Mezzanine 2


Wednesday, March 24 | 7:30PM - 10:00PM
Poster Session 3
Room: Mezzanine 2


Thursday, March 25 | 6:30AM - 8:00AM
Breakfast
Room: Mezzanine 2


Thursday, March 25 | 7:00AM - 12:00PM
Poster Setup
Room: Mezzanine 2


Thursday, March 25 | 7:00AM - 12:00PM
Poster Viewing
Room: Mezzanine 2


Thursday, March 25 | 8:00AM - 11:15AM
Immunity to Chronic and Persistent Viral Infections
Room: Van Horne C/Shaughnessy

Speaker 1 of 7
* Peter C. Doherty, University of Melbourne, Australia

Thursday, March 25 | 8:00AM - 11:15AM
Immunity to Chronic and Persistent Viral Infections
Room: Van Horne C/Shaughnessy

Speaker 2 of 7
Marcia A. Blackman, Trudeau Institute, USA
Establishment, Maintenance and Immune Control of gamma-Herpesvirus Latency

Thursday, March 25 | 8:00AM - 11:15AM
Immunity to Chronic and Persistent Viral Infections
Room: Van Horne C/Shaughnessy

Speaker 3 of 7
Ilhem Messaoudi, University of California, Irvine, USA
Short Talk: Elucidating the Role of T Cell Immunity in the Control of VZV Replication using a Novel Nonhuman Primate Model

Thursday, March 25 | 8:00AM - 11:15AM
Immunity to Chronic and Persistent Viral Infections
Room: Van Horne C/Shaughnessy

Speaker 4 of 7
Emmanuel J. Wiertz, University Medical Center Utrecht, Netherlands
Herpesvirus Interference with T-Cell Immunity

Thursday, March 25 | 8:00AM - 11:15AM
Immunity to Chronic and Persistent Viral Infections
Room: Van Horne C/Shaughnessy

Speaker 5 of 7
Elina I. Zuniga, University of California, San Diego, USA
Short Talk: Sustained-Cell-Intrinsic Transforming Growth Factor-beta Signaling Mediates Virus-Specific CD8+ T Cell Deletion and Viral Persistence in vivo

Thursday, March 25 | 8:00AM - 11:15AM
Immunity to Chronic and Persistent Viral Infections
Room: Van Horne C/Shaughnessy

Speaker 6 of 7
Barbara Rehermann, NIDDK, National Institutes of Health, USA
Immunity to Hepatitis C Virus

Thursday, March 25 | 8:00AM - 11:15AM
Immunity to Chronic and Persistent Viral Infections
Room: Van Horne C/Shaughnessy

Speaker 7 of 7
Francis V. Chisari, The Scripps Research Institute, USA
Induction and Evasion of the Innate Host Response to HCV

Thursday, March 25 | 8:00AM - 11:15AM
Novel Vaccine Approaches
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 1 of 6
Gerald H. Voss, GlaxoSmithKline Biologicals, Belgium
AS01, an Adjuvant System Potentiating Vaccines against Complex Pathogens


Thursday, March 25 | 8:00AM - 11:15AM
Novel Vaccine Approaches
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 2 of 6
Bette Tina Marie Korber, Los Alamos National Laboratory, USA
Vaccine Antigen Designs to Address HIV Variability


Thursday, March 25 | 8:00AM - 11:15AM
Novel Vaccine Approaches
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 3 of 6
Dan H. Barouch, Beth Israel Deaconess Medical Center, USA
Short Talk: Heterologous Rare Serotype Adenovirus Vectors for HIV-1 +


Thursday, March 25 | 8:00AM - 11:15AM
Novel Vaccine Approaches
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 4 of 6
* Louis J. Picker, Oregon Health & Science University, USA
Cytomegalovirus Vectors


Thursday, March 25 | 8:00AM - 11:15AM
Novel Vaccine Approaches
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 5 of 6
Brad Jones, Weill Cornell Medicine, USA
Short Talk: Comprehensive Elimination of Globally Diverse HIV Primary Isolate Infections by HERV-K-Specific CD8+ T Cells


Thursday, March 25 | 8:00AM - 11:15AM
Novel Vaccine Approaches
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 6 of 6
Wayne C. Koff, Human Vaccines Project, USA
Future Directions in AIDS Vaccine Development


Thursday, March 25 | 9:20AM - 9:40AM
Coffee Break
Room: Van Horne Foyer


Thursday, March 25 | 11:15AM - 12:00PM
Lunch
Room: Mezzanine 2


Thursday, March 25 | 12:00PM - 2:30PM
Poster Session 4
Room: Mezzanine 2


Thursday, March 25 | 2:30PM - 4:30PM
Workshop 2: Anti-Viral T and B-Cells
Room: Shaughnessy

Speaker 1 of 2
* Cornelia C. Bergmann, Cleveland Clinic Foundation, USA

Thursday, March 25 | 2:30PM - 4:30PM
Workshop 2: Anti-Viral T and B-Cells
Room: Shaughnessy

Speaker 2 of 2
* Kevin L. Legge, University of Iowa Carver College of Medicine, USA

Thursday, March 25 | 2:30PM - 3:30PM
Workshop 2A: Anti-Viral CD4 and CD8 T Cell Responses
Room: Shaughnessy

Speaker 1 of 4
Anna Haas, Swiss Federal Institute of Technology, Switzerland
HIV-1 Replication Activates CD4+ T Cells with Specificities for Persistent Herpes Viruses

Thursday, March 25 | 2:30PM - 3:30PM
Workshop 2A: Anti-Viral CD4 and CD8 T Cell Responses
Room: Shaughnessy

Speaker 2 of 4
Mickael J. Ploquin, Act Up-Paris, France
B Cells Shape the T Helper Response to Retroviral Infection

Thursday, March 25 | 2:30PM - 3:30PM
Workshop 2A: Anti-Viral CD4 and CD8 T Cell Responses
Room: Shaughnessy

Speaker 3 of 4
David E. Verhoeven, Iowa State University, USA
Memory CD4+ T-Cells Mediate Enhanced Immunopathology during Influenza Infection

Thursday, March 25 | 2:30PM - 3:30PM
Workshop 2A: Anti-Viral CD4 and CD8 T Cell Responses
Room: Shaughnessy

Speaker 4 of 4
Jennifer Bomberger, University of Pittsburgh School of Medicine, USA
The Pseudomonas aeruginosa Toxin Cif Reduces MHC Class I Antigen Presentation and Viral Immunity

Thursday, March 25 | 2:30PM - 4:30PM
Workshop 3: HIV Pathogenesis to Inform Vaccine Design
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 1 of 10
* David I. Watkins, University of Miami, USA


Thursday, March 25 | 2:30PM - 4:30PM
Workshop 3: HIV Pathogenesis to Inform Vaccine Design
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 2 of 10
* Barbara L. Shacklett, University of California, Davis, USA


Thursday, March 25 | 2:30PM - 4:30PM
Workshop 3: HIV Pathogenesis to Inform Vaccine Design
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 3 of 10
Srinika R. F. Ranasinghe, Ragon Institute of MGH, MIT and Harvard, USA
Short Talk: The Antiviral Efficacy of HIV-Specific CD8+ T-Cells to a Conserved Epitope is Heavily Dependent on the Infecting HIV-1 Isolate


Thursday, March 25 | 2:30PM - 4:30PM
Workshop 3: HIV Pathogenesis to Inform Vaccine Design
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 4 of 10
Anne-Sophie M. Dugast, Ragon Institute of MGH, MIT and Harvard, USA
Short Talk: Significant Impairment in Innate Immune Cells Recruitment by Chronic Untreated Antibodies to Mediate ADCC


Thursday, March 25 | 2:30PM - 4:30PM
Workshop 3: HIV Pathogenesis to Inform Vaccine Design
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 5 of 10
Matthew R. Reynolds, University of Wisconsin-Madison, USA
Short Talk: Macaques Vaccinated with SIVmac239deltanef Delay Acquisition and Control Replication after Repeated Low Dose Heterologous SIV Challenge


Thursday, March 25 | 2:30PM - 4:30PM
Workshop 3: HIV Pathogenesis to Inform Vaccine Design
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 6 of 10
Todd M. Allen, Ragon Institute of MGH, MIT and Harvard, USA
Short Talk: Ultra-Deep Sequencing During Acute HIV Infection Reveals the Earliest Adaptive Changes to Host Selection Pressures


Thursday, March 25 | 2:30PM - 4:30PM
Workshop 3: HIV Pathogenesis to Inform Vaccine Design
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 7 of 10
Qingsheng Li, University of Nebraska Center for Virology, USA
Short Talk: Maturation of Virus-specific Antibodies in Cervicovaginal Tissues in SIVmac239deltanef-vaccinated Macaques


Thursday, March 25 | 2:30PM - 4:30PM
Workshop 3: HIV Pathogenesis to Inform Vaccine Design
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 8 of 10
Suzanne English, University of Oxford, UK
Short Talk: Sexual Transmission of Highly-Distinct HIV-1 Variants from a Single Donor to Two Recipients on the Same Night: Divergent Immune-Recognition and Clinical Outcomes


Thursday, March 25 | 2:30PM - 4:30PM
Workshop 3: HIV Pathogenesis to Inform Vaccine Design
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 9 of 10
Suresh Pallikkuth, University of Miami, USA
Short Talk: Recombinant IL-21 Induces Cytotoxic Molecule Granzyme B in Lymph Nodes of Chronic SIV Infected Rhesus Macaques


Thursday, March 25 | 2:30PM - 4:30PM
Workshop 3: HIV Pathogenesis to Inform Vaccine Design
This session is from HIV Vaccines
Room: Van Horne Ballroom A-B

Speaker 10 of 10
Adam D. Burgener, University of Manitoba, Canada
Short Talk: HIV-1-Resistant Sex Workers Overexpress Novel Antiproteases and Antiviral Factors in their Cervical Mucosa. Protective Milieu Against HIV-1 Infection?


Thursday, March 25 | 2:30PM - 4:30PM
Workshop 3: Innate Immunity to Virus Infection
Room: Van Horne Ballroom C

Speaker 1 of 2
* Adolfo García-Sastre, Mount Sinai School of Medicine, USA

Thursday, March 25 | 2:30PM - 4:30PM
Workshop 3: Innate Immunity to Virus Infection
Room: Van Horne Ballroom C

Speaker 2 of 2
* Hans-Gustaf Ljunggren, Karolinska Institutet, Sweden

Thursday, March 25 | 2:30PM - 3:30PM
Workshop 3A: Immunity to Viruses
Room: Van Horne Ballroom C

Speaker 1 of 4
Maulik Patel, Vanderbilt University, USA
Evolution as a Guide to Molecular Mechanisms of Pathogen Resistance

Thursday, March 25 | 2:30PM - 3:30PM
Workshop 3A: Immunity to Viruses
Room: Van Horne Ballroom C

Speaker 2 of 4
Helene Minyi Liu, National Taiwan University, Taiwan
RIG-I Membrane-Association Controls Innate Antiviral Immunity

Thursday, March 25 | 2:30PM - 3:30PM
Workshop 3A: Immunity to Viruses
Room: Van Horne Ballroom C

Speaker 3 of 4
Alina Baum, Regeneron Pharmaceuticals, USA
Characterization of Endogenous RIG-I Substrates from Virus Infected Cells

Thursday, March 25 | 2:30PM - 3:30PM
Workshop 3A: Immunity to Viruses
Room: Van Horne Ballroom C

Speaker 4 of 4
Irving C. Allen, Virginia Tech, USA
NLRX1 is a Regulator of the Innate Immune Response to Influenza A Virus Infection

Thursday, March 25 | 3:30PM - 4:30PM
Workshop 3B: Innate Cellular Responses to Viruses
Room: Van Horne Ballroom C

Speaker 1 of 4
Karyl Kopaskie, University of Chicago, USA
Evasion of the Immune Response by Retroviriuses

Thursday, March 25 | 3:30PM - 4:30PM
Workshop 3B: Innate Cellular Responses to Viruses
Room: Van Horne Ballroom C

Speaker 2 of 4
Mark T. Orr, Infectious Disease Research Institute, USA
“Unlicensed” NK Cells Dominate the Response to Cytomegalovirus Infection

Thursday, March 25 | 3:30PM - 4:30PM
Workshop 3B: Innate Cellular Responses to Viruses
Room: Van Horne Ballroom C

Speaker 3 of 4
Stephen A. McCartney, Washington University School of Medicine, USA
Distinct Functions of MDA5 and TLR3 in poly-I:C-mediated Activation of Murine NK Cells

Thursday, March 25 | 3:30PM - 4:30PM
Workshop 3B: Innate Cellular Responses to Viruses
Room: Van Horne Ballroom C

Speaker 4 of 4
Stephanie Jost, Ragon Institute of MGH, MIT and Harvard, USA
Modulation of 2B4 and NKp46 Expression at the Surface of NK Cells in Response to Influenza Virus

Thursday, March 25 | 3:30PM - 4:30PM
Workshop 2B: B Cell Responses to Viruses
Room: Shaughnessy

Speaker 1 of 4
Matthew R. Vogt, Washington University School of Medicine, USA
Non-Neutralizing Antibodies Protect against Lethal West Nile Virus Infection via Fc-gamma Receptor and Complement–dependent Mechanisms

Thursday, March 25 | 3:30PM - 4:30PM
Workshop 2B: B Cell Responses to Viruses
Room: Shaughnessy

Speaker 2 of 4
Santiago F. Gonzalez, Immune Disease Institute, USA
Capture of Influenza by Medullary Dendritic Cells is Essential for Humoral Immunity in Draining Lymph Nodes

Thursday, March 25 | 3:30PM - 4:30PM
Workshop 2B: B Cell Responses to Viruses
Room: Shaughnessy

Speaker 3 of 4
Denise A. Kaminski, University of Rochester, USA
Antiviral Activity of Influenza Nucleoprotein-Specific Antibodies

Thursday, March 25 | 3:30PM - 4:30PM
Workshop 2B: B Cell Responses to Viruses
Room: Shaughnessy

Speaker 4 of 4
Luis J. Sigal, Fox Chase Cancer Center, USA
Not just Neutralizing Abs: Prevention and Cure of a Viral Disease by Antibodies that Block the Biological Function of a Virulence Factor

Thursday, March 25 | 4:30PM - 5:00PM
Coffee Available
Room: Van Horne Foyer


Thursday, March 25 | 5:00PM - 7:00PM
Antigenic Variation (Joint)
Room: Van Horne Ballroom A-B

Speaker 1 of 5
* Wayne C. Koff, Human Vaccines Project, USA

Thursday, March 25 | 5:00PM - 7:00PM
Antigenic Variation (Joint)
Room: Van Horne Ballroom A-B

Speaker 2 of 5
David I. Watkins, University of Miami, USA
The Effect of Vaccine-Induced SIV-Specific Immune Response on Viral Acquisition and Replication

Thursday, March 25 | 5:00PM - 7:00PM
Antigenic Variation (Joint)
Room: Van Horne Ballroom A-B

Speaker 3 of 5
Arnaud Moris, INSERM Université Pierre et Marie Curie (UPMC) Hôpital Pitié-Salpêtrière CNRS, France
Short Talk: The Antiviral Factor APOBEC3G Improves CTL Recognition of HIV-Infected T Cells: Linking Intrinsic and Adaptive Immune Responses

Thursday, March 25 | 5:00PM - 7:00PM
Antigenic Variation (Joint)
Room: Van Horne Ballroom A-B

Speaker 4 of 5
Dennis R. Burton, The Scripps Research Institute, USA
HIV Env and Approaches to Neutralizing Abs

Thursday, March 25 | 5:00PM - 7:00PM
Antigenic Variation (Joint)
Room: Van Horne Ballroom A-B

Speaker 5 of 5
Jonathan W. Yewdell, NIAID, National Institutes of Health, USA
Still Drifting: Mechanisms of Influenza A Virus Hemagglutinin Immune Escape

Thursday, March 25 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Mezzanine 2


Thursday, March 25 | 8:00PM - 11:00PM
Entertainment
Room: Mezzanine 2


Thursday, March 25 | 8:00PM - 11:00PM
Cash Bar
Room: Mezzanine 2


Friday, March 26 | 10:25AM - 10:25AM
Departure


*Session Chair.